Cover Image
市場調查報告書

Intec Pharma ltd.:產品平台分析

Intec Pharma ltd. - Product Pipeline Review - 2015

出版商 Global Markets Direct 商品編碼 305692
出版日期 內容資訊 英文 24 Pages
訂單完成後即時交付
價格
Back to Top
Intec Pharma ltd.:產品平台分析 Intec Pharma ltd. - Product Pipeline Review - 2015
出版日期: 2015年02月28日 內容資訊: 英文 24 Pages
簡介

本報告提供Intec Pharma ltd.的治療藥開發平台現狀及各開發階段的比較分析,提供您藥物標的,作用機制,給藥途徑,各分子類型的治療藥評估,彙整最新的企業新聞和發表,後期階段及中止的計劃相關資訊等。

Intec Pharma ltd.的基本資料

Intec Pharma ltd.概要

  • 主要資訊
  • 企業資料

Intec Pharma ltd.:R&D概要

  • 主要的治療範圍

Intec Pharma ltd.:開發平台評估

  • 各開發階段的開發中產品
  • 單劑產品
  • 聯合治療模式

Intec Pharma ltd.:開發中產品概況

  • 臨床實驗階段的開發中產品
    • 第二階段的產品/聯合治療模式
    • 第一階段的產品/聯合治療模式
  • 初期階段的開發中產品
    • 前臨床階段的產品/聯合治療模式

Intec Pharma ltd.:藥物簡介

  • (carbidopa + levodopa)
  • zaleplon GR
  • baclofen GR
  • Several Undisclosed Projects

Intec Pharma ltd.:開發平台分析

  • 標的別
  • 各給藥途徑
  • 各分子類型
  • 各作用機制

Intec Pharma ltd.:最近的開發平台趨勢

Intec Pharma ltd.:總公司和子公司的所在地

附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GMDHC06809CDB

Summary

Global Markets Direct's, 'Intec Pharma ltd. - Product Pipeline Review - 2015', provides an overview of the Intec Pharma ltd.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Intec Pharma ltd.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of Intec Pharma ltd. including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of Intec Pharma ltd.'s human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the Intec Pharma ltd.'s pipeline products

Reasons to buy

  • Evaluate Intec Pharma ltd.'s strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of Intec Pharma ltd. in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the Intec Pharma ltd.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of Intec Pharma ltd. and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of Intec Pharma ltd.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of Intec Pharma ltd. and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Intec Pharma ltd. Snapshot
    • Intec Pharma ltd. Overview
    • Key Information
    • Key Facts
  • Intec Pharma ltd. - Research and Development Overview
    • Key Therapeutic Areas
  • Intec Pharma ltd. - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
    • Pipeline Products - Combination Treatment Modalities
  • Intec Pharma ltd. - Pipeline Products Glance
    • Intec Pharma ltd. - Clinical Stage Pipeline Products
      • Phase II Products/Combination Treatment Modalities
    • Intec Pharma ltd. - Early Stage Pipeline Products
      • Preclinical Products/Combination Treatment Modalities
  • Intec Pharma ltd. - Drug Profiles
    • (carbidopa + levodopa)
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • zaleplon GR
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Drugs for Undisclosed Indication
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • Intec Pharma ltd. - Pipeline Analysis
    • Intec Pharma ltd. - Pipeline Products by Target
    • Intec Pharma ltd. - Pipeline Products by Route of Administration
    • Intec Pharma ltd. - Pipeline Products by Molecule Type
    • Intec Pharma ltd. - Pipeline Products by Mechanism of Action
  • Intec Pharma ltd. - Recent Pipeline Updates
  • Intec Pharma ltd. - Dormant Projects
  • Intec Pharma ltd. - Locations And Subsidiaries
    • Head Office
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • Intec Pharma ltd., Key Information
  • Intec Pharma ltd., Key Facts
  • Intec Pharma ltd. - Pipeline by Indication, 2015
  • Intec Pharma ltd. - Pipeline by Stage of Development, 2015
  • Intec Pharma ltd. - Monotherapy Products in Pipeline, 2015
  • Intec Pharma ltd. - Combination Treatment Modalities in Pipeline, 2015
  • Intec Pharma ltd. - Phase II, 2015
  • Intec Pharma ltd. - Preclinical, 2015
  • Intec Pharma ltd. - Pipeline by Target, 2015
  • Intec Pharma ltd. - Pipeline by Route of Administration, 2015
  • Intec Pharma ltd. - Pipeline by Molecule Type, 2015
  • Intec Pharma ltd. - Pipeline Products by Mechanism of Action, 2015
  • Intec Pharma ltd. - Recent Pipeline Updates, 2015
  • Intec Pharma ltd. - Dormant Developmental Projects,2015

List of Figures

  • Intec Pharma ltd. - Pipeline by Top 10 Indication, 2015
  • Intec Pharma ltd. - Pipeline by Stage of Development, 2015
  • Intec Pharma ltd. - Monotherapy Products in Pipeline, 2015
  • Intec Pharma ltd. - Pipeline by Top 10 Target, 2015
  • Intec Pharma ltd. - Pipeline Products by Top 10 Mechanism of Action, 2015
Back to Top